Abel González-Pérez

Pan-cancer analysis of whole genomes

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse et al. · Nature · 2020 · 3.1K citations · Full text

Comprehensive Characterization of Cancer Driver Genes and Mutations

Matthew H. Bailey, Collin Tokheim, Eduard Porta‐Pardo et al. · Cell · 2018 · 2.4K citations · Full text

Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes

Mark D.M. Leiserson, Fabio Vandin, Hsin-Ta Wu et al. · Nature Genetics · 2014 · 969 citations · Full text

Improving the Assessment of the Outcome of Nonsynonymous SNVs with a Consensus Deleteriousness Score, Condel

Abel González-Pérez, Núria López-Bigas · The American Journal of Human Genetics · 2011 · 771 citations · Full text

Reliability, Nonsynonymous Snvs, Patient Safety +6

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Joaquı́n Mateo, Debyani Chakravarty, Rodrigo Dienstmann et al. · Annals of Oncology · 2018 · 728 citations · Full text